Loading company…
Helsinki company developing AI tools for radiation therapy, including the Dose+ planning product and the GBS segmentation suite.
MVision AI Oy, founded in 2017 in Helsinki, Finland, by Aleksi Nurmi, Jarkko Niemela, Mahmudul Hasan and Saad Akram, develops AI-powered solutions for radiation therapy. Its Dose+ product predicts patient-specific doses to speed treatment planning, and its Guideline-Based Segmentation suite includes Contour+, Verify and Guide. Customers are radiation oncology providers in 20 countries, and revenue comes from subscriptions and licensing. In March 2023 the company raised EUR 5.4 million from J12 Ventures and Voima Ventures, and Jarkko Niemela is CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in